➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
McKesson
Colorcon
Boehringer Ingelheim
Express Scripts

Last Updated: May 9, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Aspartame

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Aspartame?

Aspartame is an investigational drug.

There have been 5 clinical trials for Aspartame. The most recent clinical trial was a Phase 2 trial, which was initiated on March 8th 2019.

The most common disease conditions in clinical trials are Diabetes Mellitus, Kidney Diseases, and Diabetic Nephropathies. The leading clinical trial sponsors are Universal Integrated Corp., Singapore General Hospital, and National Medical Research Council (NMRC), Singapore.

There are two US patents protecting this investigational drug and thirty-four international patents.

Recent Clinical Trials for Aspartame
TitleSponsorPhase
Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to ColonoscopyUniversal Integrated Corp.Phase 3
Effects of Fenofibrate Therapy in Diabetic NephropathyNational Medical Research Council (NMRC), SingaporePhase 3
Effects of Fenofibrate Therapy in Diabetic NephropathySingapore General HospitalPhase 3

See all Aspartame clinical trials

Clinical Trial Summary for Aspartame

Top disease conditions for Aspartame
Top clinical trial sponsors for Aspartame

See all Aspartame clinical trials

US Patents for Aspartame

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aspartame   Get Started for $10 Cyclic boronic acid ester derivatives and methods of making the same Rempex Pharmaceuticals, Inc. (San Diego, CA)   Get Started for $10
Aspartame   Get Started for $10 Pharmaceutical composition for preventing or treating skin cancer comprising Panax spp. plant extract and method of preventing or treating skin cancer in a subject using the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, KR)   Get Started for $10
Aspartame   Get Started for $10 Non-caloric sweeteners and methods for synthesizing Conagen Inc. (Bedford, MA)   Get Started for $10
Aspartame   Get Started for $10 Non-caloric sweeteners and methods for synthesizing Conagen Inc. (Bedford, MA)   Get Started for $10
Aspartame   Get Started for $10 Small molecule HSP70 inhibitors The Trustees of the University of Pennsylvania (Philadelphia, PA) The Wistar Institute of Anatomy and Biology (Philadelphia, PA)   Get Started for $10
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Aspartame

Drugname Country Document Number Estimated Expiration Related US Patent
Aspartame Australia AU2011289615 2030-08-10   Get Started for $10
Aspartame Brazil BR112013003045 2030-08-10   Get Started for $10
Aspartame Canada CA2807546 2030-08-10   Get Started for $10
Aspartame Chile CL2013000399 2030-08-10   Get Started for $10
Aspartame China CN103180328 2030-08-10   Get Started for $10
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Mallinckrodt
Merck
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.